ARCHIVES

Secondary AML In High-Dose Chemo Trial Cause For Careful Monitoring, NCI Says

This article is from The Cancer Letter archive.

Vol. 20 No. 33 | August 19, 1994

Download PDF Visit The Full Archive

Related Articles

An Alliance of NSABP-RTOG And GOG?

March 25, 2011

First TIL Results: Four Patients, All Responded, One Complete; Panel Pens Reauthorization Drive

November 27, 1987

Letters: NCI Mammography Statement Recognizes Patient Autonomy

February 25, 1994

Flood Says Congress Will Renew Cancer Act, But Only After “All Out” Review of Research Policy

December 3, 1976

Congress Passes NIH Reauthorization.

December 15, 2006

Carcinogenicity Test For Cis-Platinum Needed, DCT Says, But Declines To Pay For It

June 16, 1978